{"entity":{"type":"insider","cik":"0001978096","url":"/insider/0001978096","json_url":"/insider/0001978096.json","name":"Henrich Jill","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":7,"first":"2023-08-18","last":"2025-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Henrich Jill","source":"filing","n_filings":7,"first_seen":"2023-08-18","last_seen":"2025-03-05"}],"transactions":[{"id":4612512,"accession":"0000905148-25-000863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-25-000863","line_url":"/filing/0000905148-25-000863#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001978096","owner_name":"Henrich Jill","owner_display_name":"Henrich Jill","owner_url":"/insider/0001978096","role":"Officer (EVP, Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1059.0,"shares_display":"1,059","price_per_share":6.997,"price_display":"7.00","price_state":"stated","total_value":7409.823,"total_display":"7,409.82","total_whole":"7,410","shares_owned_after":18679.0,"shares_owned_after_display":"18,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":3245979,"accession":"0000905148-24-003243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-003243","line_url":"/filing/0000905148-24-003243#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001978096","owner_name":"Henrich Jill","owner_display_name":"Henrich Jill","owner_url":"/insider/0001978096","role":"Officer (EVP, Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":11.198,"price_display":"11.20","price_state":"stated","total_value":11198.0,"total_display":"11,198.00","total_whole":"11,198","shares_owned_after":19378.0,"shares_owned_after_display":"19,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-20","scope":"insider"},{"id":2942017,"accession":"0000905148-24-002302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-24-002302","line_url":"/filing/0000905148-24-002302","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001978096","owner_name":"Henrich Jill","owner_display_name":"Henrich Jill","owner_url":"/insider/0001978096","role":"Officer (EVP, Global Head RA & Quality)","role_mark":"O","role_mark_label":"Officer (EVP, Global Head RA & Quality)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Head RA & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":963.0,"shares_display":"963","price_per_share":6.6292741433021805,"price_display":"6.63","price_state":"stated","total_value":6383.991,"total_display":"6,383.99","total_whole":"6,384","shares_owned_after":20510.0,"shares_owned_after_display":"20,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-20","scope":"insider","n_lines":2},{"id":2846771,"accession":"0000905148-24-001557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-001557","line_url":"/filing/0000905148-24-001557#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001978096","owner_name":"Henrich Jill","owner_display_name":"Henrich Jill","owner_url":"/insider/0001978096","role":"Officer (EVP, Global Head RA & Quality)","role_mark":"O","role_mark_label":"Officer (EVP, Global Head RA & Quality)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Head RA & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25750.0,"shares_display":"25,750","price_per_share":0.617,"price_display":"0.62","price_state":"stated","total_value":15887.75,"total_display":"15,887.75","total_whole":"15,888","shares_owned_after":529251.0,"shares_owned_after_display":"529,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":2338496,"accession":"0000905148-24-000907","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-000907","line_url":"/filing/0000905148-24-000907#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001978096","owner_name":"Henrich Jill","owner_display_name":"Henrich Jill","owner_url":"/insider/0001978096","role":"Officer (EVP, Global Head RA & Quality)","role_mark":"O","role_mark_label":"Officer (EVP, Global Head RA & Quality)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Head RA & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3879.0,"shares_display":"3,879","price_per_share":0.72,"price_display":"0.72","price_state":"stated","total_value":2792.88,"total_display":"2,792.88","total_whole":"2,793","shares_owned_after":555001.0,"shares_owned_after_display":"555,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8101988,"accession":"0000905148-23-001508","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-23-001508","line_url":"/filing/0000905148-23-001508#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001978096","owner_name":"Henrich Jill","owner_display_name":"Henrich Jill","owner_url":"/insider/0001978096","role":"Officer (EVP, Global Head RA & Quality)","role_mark":"O","role_mark_label":"Officer (EVP, Global Head RA & Quality)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Head RA & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3267.0,"shares_display":"3,267","price_per_share":0.389,"price_display":"0.39","price_state":"stated","total_value":1270.863,"total_display":"1,270.86","total_whole":"1,271","shares_owned_after":104424.0,"shares_owned_after_display":"104,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"},{"id":8103446,"accession":"0001140361-23-040559","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-040559","line_url":"/filing/0001140361-23-040559","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001978096","owner_name":"Henrich Jill","owner_display_name":"Henrich Jill","owner_url":"/insider/0001978096","role":"Officer (EVP, Global Head RA & Quality)","role_mark":"O","role_mark_label":"Officer (EVP, Global Head RA & Quality)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Head RA & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3346.0,"shares_display":"3,346","price_per_share":1.653166766288105,"price_display":"1.65","price_state":"stated","total_value":5531.496,"total_display":"5,531.50","total_whole":"5,531","shares_owned_after":108249.0,"shares_owned_after_display":"108,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-18","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (EVP, Chief Regulatory Officer)","n_filings":7,"first_seen":"2023-08-18","last_seen":"2025-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001978096","retrieved_at":"2026-08-24T09:06:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}